Identity
What is AOD9604?
A modified hGH fragment (residues 177–191 with an added tyrosine).

Research reference · Weight & Metabolism
AOD9604 is a modified fragment of the C-terminal end of human growth hormone, studied in mouse metabolic models and in early human obesity trials that did not lead to approval.
Published by Elevated Pharma ·
Identity
A modified hGH fragment (residues 177–191 with an added tyrosine).
Research context
Published work includes mouse fat-metabolism studies, a rabbit joint model and doping-detection methods.
Evidence boundary
Mouse findings do not establish human effectiveness or safety.
U.S. status · November 7, 2026
Not FDA-approved. FDA has cited insufficient safety information for compounded AOD-9604.
Key studies
Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.
Search all 22 PubMed records for AOD9604 · Counts and selections checked November 7, 2026.
Reference identifiers
Database identity describes the reference substance, not any specific material or lot.
Official & primary sources
Citation does not imply an Elevated Pharma partnership or endorsement.